References
- Vane, J R.; Anggard, E E.; Botting, R M. Regulatory functions of the vascular endothelium.N. Engl. J. Med. 1990, 323, 27–36. [PUBMED], [INFOTRIEVE], [CSA]
- Yanagisawa, M.; Kurihara, H.; Kimura, S.; Yomobe, Y.; Kobayashi, M.; Mitssui, Y.; , et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells.Nature 1988, 332, 411–415. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wagner, O F.; Christ, G.; Wojta, J. Polar secretion of endothelin-1 by cultured endothelial cells.J. Biol. Chem. 1992, 267, 16066–16068. [PUBMED], [INFOTRIEVE], [CSA]
- Mather, K.; Mirzamohammadi, B.; Lteif, A.; Steinberg, H.; Baron, A. Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes.Diabetes 2002, 51, 3517–3523. [PUBMED], [INFOTRIEVE], [CSA]
- Haynes, W G.; Webb, D J. Contribution of endogenous generation of endothelin-1 to basal vascular tone in man.Lancet 1994, 244, 852–854. [CSA], [CROSSREF]
- Akizawa, T.; Kinugasa, E.; Koshikawa, S. Endothelin and platelet activating factor. Possible indices for biocompatibility of hemodialysis.ASAIO Trans. 1991, 37, M384–M385. [PUBMED], [INFOTRIEVE], [CSA]
- Koyama, H.; Tabata, T.; Nishzawa, Y.; Inoue, T.; Morii, H.; Yamaji, T. Plasma endothelin levels in patients with uraemia.Lancet 1989, 1, 991–992. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Mallamaci, F.; Parlongo, S.; Zoccali, C. Influence of cardiovascular damage and residual renal function on plasma endothelin in chronic renal failure.Nephron 1993, 63, 291–295. [PUBMED], [INFOTRIEVE], [CSA]
- Niwa, T.; Fujishiro, T.; Uema, K.; , et al. Effect of hemodialysis on plasma levels of vasoactive peptides: endothelin, calcitonin gene-related peptide and human atrial natriuretic peptide.Nephron 1993, 64, 552–559. [PUBMED], [INFOTRIEVE], [CSA]
- Stockenhuber, F.; Gottsauner-Wolf, M.; Marosi, L.; Liebisch, B.; Kurz, R W.; Balcke, P. Plasma levels of endothelin in chronic renal failure and after renal transplantation: impact on hypertension and cyclosporin A-associated nephrotoxicity.Clin. Sci. Colch. 1992, 82, 255–258. [PUBMED], [INFOTRIEVE], [CSA]
- Warrens, A N.; Cassidy, M J.; Takahashi, K.; Ghatei, M A.; Bloom, S R. Endothelin in renal failure.Nephrol. Dial. Transplant. 1990, 5, 418–422. [PUBMED], [INFOTRIEVE], [CSA]
- Stefanidis, I.; Mertens, P R.; Wurth, P.; Bach, R.; Makropoulos, W.; Mann, H.; , et al. Influence of recombinant human erythropoietin therapy on plasma endothelin-1 levels during hemodialysis.Int. J. Artif. Organs 2001, 24, 367–373. [PUBMED], [INFOTRIEVE], [CSA]
- Lebel, M.; Grose, J H.; Kingma, I.; Langlois, S. Plasma endothelin levels and blood pressure in hemodialysis and in CAPD patients. Effect of subcutaneous erythropoietin replacement therapy.Clin. Exp. Hypertens. 1994, 16, 565–575. [PUBMED], [INFOTRIEVE], [CSA]
- DeVriese, A.; Verbeuren, T.; Van de Voorde, J.; Lameire, N.; Vanhoutte, P. Endothelial dysfunction in diabetes.Br. J. Pharmacol. 2000, 130, 963–974. [CSA], [CROSSREF]
- Takeda, Y.; Miyamori, I.; Yoneda, T.; Takeda, R. Production of endothelin-1 from the mesenteric artery of streptozotocin-induced diabetic rats.Life Sci. 1991, 48, 2553–2556.. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Makino, A.; Kamata, K. Elevated plasma endothelin-1 level in streptozotocin-induced diabetic rats and responsiveness of mesenteric arterial bed to endothelin-1.Br. J. Pharmacol. 1998, 123, 1065–1072. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hopfner, R.; McNeill, J.; Gopalakrishnan, V. Endothelin plasma levels and endothelin-1 evoked vascular responses at different temporal stages of diabetes in streptozotocin rats.Eur. J. Pharmacol. 1999, 374, 221–227. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hattori, Y.; Kassai, K.; Nakamura, T.; Emoto, T.; Shimoda, S. Effect of glucose and insulin on immunoreactive endothelin-1 release from cultured porcine aortic endothelial cells.Metabolism 1991, 40, 165–170. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Donatelli, M.; Colletti, I.; Bucalo, M.; Russo, V.; Verga, S. Plasma endothelin levels in NIDDM patients with macroangiopathy.Diabetes Res. 1994, 25, 159–164. [PUBMED], [INFOTRIEVE], [CSA]
- Morise, T.; Takeuchi, Y.; Kawano, M.; Koni, I.; Takeda, R. Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients.Diabetes Care 1997, 18, 87–89. [CSA]
- Guvener, N.; Aytemir, K.; Aksoyek, S.; Gedik, O. Plasma endothelin-1 levels in non-insulin dependent diabetes mellitus patients with macrovascular disease.Coron. Artery Dis. 1997, 8, 253–258. [PUBMED], [INFOTRIEVE], [CSA]
- Migdalis, I.; Kalogeropoulou, K.; Iliopoulou, V.; Triantafilou, P.; Charalabides, J.; Mortzos, G.; , et al. Plasma levels of endothelin, lipid peroxides and prostacyclin in diabetic patients with macroangiopathy.Diabetes Res. Clin. Pract. 2001, 54, 129–136. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bagg, W.; Ferri, C.; Desideri, G.; Gamble, G.; Ockelford, P.; Braatvedt, G. The influence of obesity and glycemic control on endothelial activation in patients with type 2 diabetes.J. Clin. Endocrinol. Metab. 2001, 86, 5491–5497. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Piatti, P.; Monti, L.; Galli, L.; Fragasso, G.; Valsecchi, G.; Conti, M.; , et al. Relationship between endothelin-1 concentration and metabolic alterations typical of the insulin resistance syndrome.Metabolism 2000, 49, 748–752. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wolesen, F.; Berglund, L.; Berne, C. Plasma endothelin-1 and total onsulin exposure in diabetes mellitus.Clin. Sci. Colch. 1999, 97, 149–156. [CSA], [CROSSREF]
- Chakrabarti, S.; Khan, Z.; Cukiernik, M.; Fukuda, G.; Chen, S.; , et al. Alteration of endothelins: a common pathogenetic mechanism in chronic diabetic complications.Int. J. Exp. Diabetes Res. 2002, 3, 217–231. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- van Beaumont, W. Evaluation of hemoconcentration from hematocrit measurements.J. Appl. Physiol. 1972, 32, 712–713. [PUBMED], [INFOTRIEVE], [CSA]
- Mann, H.; Stefanidis, I.; Reinhardt, B.; Stiller, S. Prevention of haemodynamic risks by continuous blood volume measurement and control.Nephrol. Dial. Transplant. 1996, 11 (Suppl. 2), 48–51. [PUBMED], [INFOTRIEVE], [CSA]
- Banks, R O. Effects of endothelin on renal function in dogs and rats.Am. J. Physiol. 1990, 258, F775–F780. [PUBMED], [INFOTRIEVE], [CSA]
- Cao, L Q.; Banks, R O. Cardiovascular and renal actions of endothelin: effects of calcium-channel blockers.Am. J. Physiol. 1990, 258, F254–F258. [PUBMED], [INFOTRIEVE], [CSA]
- Kohno, M.; Murakawa, K.; Yasunari, K.; Yokokawa, K.; Horio, T.; Kurihara, N.; , et al. Prolonged blood pressure elevation after endothelin administration in bilaterally nephrectomized rats.Metabolism 1989, 38, 712–713. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lariviere, R.; D'Amours, M.; Lebel, M.; Kingma, I.; Grose, J H.; Caron, L. Increased immunoreactive endothelin-1 levels in blood vessels and glomeruli of rats with reduced renal mass.Kidney Blood Press. Res. 1997, 20, 372–380. [PUBMED], [INFOTRIEVE], [CSA]
- Deray, G.; Carayon, A.; Maistre, G.; Benhmida, M.; Masson, F.; Barthelemy, C.; , et al. Endothelin in chronic renal failure.Nephrol. Dial. Transplant. 1992, 7, 300–305. [PUBMED], [INFOTRIEVE], [CSA]
- Miyauchi, T.; Suzuki, N.; Kurihara, T.; Yamaguchi, I.; Sugishita, Y.; Matsumoto, H.; , et al. Endothelin-1 and endothelin-3 play different roles in acute and chronic alterations of blood pressure in patients with chronic hemodialysis.Biochem. Biophys. Res. Commun. 1991, 178, 276–281. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ross, R D.; Kalidindi, V.; Vincent, J A.; Kassab, J.; Dabbagh, S.; Hsu, J M.; , et al. Acute changes in endothelin-1 after hemodialysis for chronic renal failure.J. Pediatr. 1993, 122, S74–S76. [PUBMED], [INFOTRIEVE], [CSA]
- Surdacki, A.; Sulowicz, W.; Wieczorek-Surdacka, E.; Herman, Z S. Effect of a hemodialysis session on plasma levels of endothelin-1 in hypertensive and normotensive subjects with end-stage renal failure.Nephron 1999, 81, 31–36. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kohno, M.; Yasunari, K.; Yokokawa, K.; Murakawa, K.; Horio, T.; Kanayama, Y.; , et al. Thrombin stimulates the production of immunoreactive endothelin-1 in cultured human umbilical vein endothelial cells.Metabolism 1990, 39, 1003–1005. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Carlini, R G.; Gupta, A.; Liapis, H.; Rothstein, M. Endothelin-1 release by erythropoietin involves calcium signaling in endothelial cells.J. Cardiovasc. Pharmacol. 1995, 26, 889–892. [PUBMED], [INFOTRIEVE], [CSA]
- Carlini, R.; Obialo, C I.; Rothstein, M. Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients.Am. J. Hypertens. 1993, 6, 103–107. [PUBMED], [INFOTRIEVE], [CSA]
- Yokokawa, K.; Kohno, M.; Tahara, H.; Mandal, A K.; Yasunari, K.; Murakawa, K.; Horio, T.; Ikeda, M.; Minami, M.; Takeda, T. Effect of heparin on endothelin-1 production by cultured human endothelial cells.J. Cardiovasc. Pharmacol. 1993, 22 (Suppl. 8), S46–S48. [PUBMED], [INFOTRIEVE], [CSA]
- Ferri, C.; Pittoni, V.; Piccoli, A.; Laurenti, O.; Cassone, M.; Bellini, C.; , et al. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo.J. Clin. Endocrinol. Metab. 1995, 80, 829–835. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- De Mattia, G.; Casone-Faldetta, M.; Bellini, C.; Bravi, M.; Laurenti, O.; Baldonici, R.; , et al. Role of plasma and urinary endothelin-1 in early diabetic and hypertensive nephropathy.Am. J. Hypertens. 1998, 11, 983–988. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cardillo, C.; Campia, U.; Bryant, M.; Panza, J. Increased activity of endogenous endothelin in patients with type II diabetes mellitus.Circulation 2002, 106, 1783–1787. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lerman, A.; Edward, B.; Hallet, J.; Heublein, D.; Sandberg, S.; Burnett, J J. Circulating and tissue immunoreactivity in advanced atherosclerosis.N. Engl. J. Med. 1991, 325, 997–1001. [PUBMED], [INFOTRIEVE], [CSA]
- Stefanidis, I.; Wurth, P.; Mertens, P R.; Ikonomov, V.; Philippidis, G.; Golphinopoulos, S.; , et al. Plasma endothelin-1 9n hemodialysis treatment—the influence of hypertension.J. Cardiovasc. Pharmacol. 2004, 44, 543–548. [CSA], [CROSSREF]